NephroGenex, Inc.
Industry
- Pharmaceuticals
- Specialty Pharmaceuticals
- Biotechnology
Latest on NephroGenex, Inc.
FDA might need a program to keep track of the players in a citizen petition asking the agency to reverse its decision that a common form of vitamin B6, pyridoxamine, is not a dietary ingredient and re
If news out of two small biotechs is any indication, the winds of change are in the air for the sector, indicating times of plenty are over. Two once-promising biotechs are now trading in penny stock
IN VITRO DIAGNOSTICS Alliances Dentamed Ltd. Diamedica Ltd. SIRAM Ltd. Vigilant Biosciences Inc. Vigilant Biosciences Inc. signed three new multi-year distribution agreements for marketing of its
IN VITRO DIAGNOSTICS Mergers & Acquisitions PDI Inc. Interpace Diagnostics LLC RedPath Integrated Pathology Inc. PDI Inc. acquired molecular diagnostics company RedPath Integrated Pathology Inc.